Clean Science
Specialty Chemicals · CLEAN
Mid CapBasic MaterialsHigh Growth
Ashok Boob
Managing Director · Pragmatic
Company DNA
Founder-Centric
About
Clean Science is a Mid Cap company in the Basic Materials sector, listed on NSE as CLEAN. With a market cap of ₹8K Cr and revenue of ₹950 Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Disruptor approach to innovation, the company operates at a Steady-Marathon pace. Strong promoter control and promoter-led management style typical of high-growth specialty chemical startups. Its strategic mandate: Needs sustained R&D investment and product innovation to maintain its competitive edge in the high-margin specialty chemicals segment.
FAQ
What kind of company is Clean Science?
Clean Science is a Mid Cap Basic Materials company (CLEAN) in the High Growth phase with a market cap of ₹8K Cr. It is classified as Founder-Centric in culture.
What is Clean Science's culture and work environment like?
Clean Science has a Founder-Centric culture with Disruptor innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Strong promoter control and promoter-led management style typical of high-growth specialty chemical startups.
Who leads Clean Science?
Clean Science is led by Ashok Boob (Managing Director), a Pragmatic leader with 51 years of experience.
What are Clean Science's financials?
Clean Science reported revenue of ₹950 Cr in FY25 with a 5-year revenue CAGR of 11.9%. Operating margin: 33.6%. Market cap: ₹8K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationDisruptor
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleHigh Growth
Strong promoter control and promoter-led management style typical of high-growth specialty chemical startups.
Mandate
Needs sustained R&D investment and product innovation to maintain its competitive edge in the high-margin specialty chemicals segment.
Needs sustained R&D investment and product innovation to maintain its competitive edge in the high-margin specialty chemicals segment.
Financials
Revenue FY25₹950 Cr
PAT FY25₹264 Cr
Rev CAGR 5Y11.9%
OPM33.6%
NPM27.8%
ROE18.7%
ROCE22%
P/E30.3
Fwd P/E0.3
P/B5
D/E0.1
Mkt Cap₹8K Cr
Promoter54.9%
Institutional22.4%
Similar Culture
Could You Lead Clean Science?
Take the Genome Benchmark →